These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA. Airaksinen EM; Leino E Acta Neurol Scand; 1982 Dec; 66(6):666-72. PubMed ID: 6187174 [TBL] [Abstract][Full Text] [Related]
6. Homovanillic acid and 5-hydroxyindoleacetic acid modifications in CSF of patients with stroke and multi-infarct dementia. Smirne S; Franceschi M; Truci G; Camerlingo M; Pirola R; Ferini-Strambi L; Bareggi SR Stroke; 1985; 16(6):1003-6. PubMed ID: 2418548 [TBL] [Abstract][Full Text] [Related]
7. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease. Gibson CJ; Logue M; Growdon JH Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838 [TBL] [Abstract][Full Text] [Related]
9. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850 [TBL] [Abstract][Full Text] [Related]
10. The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and the effects of ACTH treatment. Airaksinen E; Tuomisto L; Riikonen R Brain Dev; 1992 Nov; 14(6):386-90. PubMed ID: 1283505 [TBL] [Abstract][Full Text] [Related]
11. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment]. Yamamoto M; Otsuki S; Miyake K; Namba R No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804 [No Abstract] [Full Text] [Related]
12. Laboratory examinations correlated with severity of dementia. Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434 [TBL] [Abstract][Full Text] [Related]
13. CSF monoamine metabolites in old age dementias. Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590 [TBL] [Abstract][Full Text] [Related]
14. Isoniazid effects on choreiform movement and on GABA, HVA, and 5-HIAA in CSF. Yamamoto M; Otsuki S; Kuroda H; Ogawa N Acta Neurol Scand; 1983 Feb; 67(2):124-7. PubMed ID: 6189358 [TBL] [Abstract][Full Text] [Related]
15. Concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid from human infants in the perinatal period. Silverstein FS; Donn S; Buchanan K; Johnston MV J Neurochem; 1984 Dec; 43(6):1769-72. PubMed ID: 6208340 [TBL] [Abstract][Full Text] [Related]
16. CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly. Lee S; Chiba T; Kitahama T; Kaieda R; Hagiwara M; Nagazumi A; Terashi A J Neural Transm Suppl; 1990; 30():45-55. PubMed ID: 1697333 [TBL] [Abstract][Full Text] [Related]
17. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study. Morimoto S; Takao M; Hatsuta H; Nishina Y; Komiya T; Sengoku R; Nakano Y; Uchino A; Sumikura H; Saito Y; Kanemaru K; Murayama S PLoS One; 2017; 12(2):e0171524. PubMed ID: 28166276 [TBL] [Abstract][Full Text] [Related]
18. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Gerner RH; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Hare TA; Shaywitz BA; Cohen DJ Am J Psychiatry; 1984 Dec; 141(12):1533-40. PubMed ID: 6209989 [TBL] [Abstract][Full Text] [Related]
19. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus. Inagawa T; Ishikawa S; Uozumi T J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788 [TBL] [Abstract][Full Text] [Related]
20. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit. Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]